Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
TLX592 / Telix
CUPID, NCT04726033: 64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study ( Study)	Completed	1	14	RoW	64Cu-DOTA-TLX592, 64Cu-TLX592	Telix Pharmaceuticals (Innovations) Pty Limited	Metastatic Prostate Cancer	12/23	01/24